ArticleRadiology case reports2024
High-grade astrocytoma with piloid features: MRI findings associated with a novel entity.
Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort.Neuro-oncology · 2026Article
- High-grade astrocytoma with piloid features resected with an exoscopic supracerebellar infratentorial approach: illustrative case.Journal of neurosurgery. Case lessons · 2025Article
- High-grade astrocytoma with piloid features: A case report and review of literature.Surgical neurology international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-grade astrocytoma with piloid features is a newly defined brain tumor that requires DNA methylation profiling for diagnosis. Imaging features specific to this tumor have only recently been described in the radiological literature. We highlight the case of a 34-year-old man who presented with a 4-week history of headaches and light-headedness. Postresection, pathological analysis identified the tumor based on DNA methylation profiling, and the patient was started on adjuvant chemotherapy with Temozolomide. T2-weighted imaging showed a well-circumscribed cerebellar mass, which correlated with the pathology-reported glial tumor cells being elongated and piloid. T1-postgadolinium imaging showed heterogeneous enhancement of linear serpiginous areas, which correlated with regions of high microvascular density and vessels that showed thickening and hyalinization. Diffusion-weighted imaging and apparent diffusion coefficient mapping did not show significant diffusion restriction. Rosenthal fibres were absent. Given the specific imaging-pathology correlation, this report contributes imaging features associated with this novel diagnostic entity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.